Supernus Pharmaceuticals (NASDAQ:SUPN) Lifted to Buy at StockNews.com
StockNews.com upgraded shares of Supernus Pharmaceuticals (NASDAQ:SUPN – Free Report) from a hold rating to a buy rating in a research note released on Wednesday. Separately, Piper Sandler lifted their target price on shares of Supernus Pharmaceuticals from $42.00 to $43.00 and gave the company an overweight rating in a report on Thursday, November 9th. […]
More Stories
RFG Advisory LLC Sells 17,290 Shares of Dimensional US Core Equity Market ETF (NYSEARCA:DFAU)
RFG Advisory LLC cut its position in shares of Dimensional US Core Equity Market ETF (NYSEARCA:DFAU – Free Report) by...
LexAurum Advisors LLC Buys Shares of 4,000 SPDR Portfolio S&P 500 Value ETF (NYSEARCA:SPYV)
LexAurum Advisors LLC purchased a new stake in shares of SPDR Portfolio S&P 500 Value ETF (NYSEARCA:SPYV – Free Report)...
LexAurum Advisors LLC Acquires New Shares in Warner Bros. Discovery, Inc. (NASDAQ:WBD)
LexAurum Advisors LLC acquired a new position in shares of Warner Bros. Discovery, Inc. (NASDAQ:WBD – Free Report) in the...
LexAurum Advisors LLC Cuts Position in Pimco Total Return ETF (NYSEARCA:BOND)
LexAurum Advisors LLC trimmed its position in shares of Pimco Total Return ETF (NYSEARCA:BOND – Free Report) by 67.5% during...
LexAurum Advisors LLC Has $441,000 Holdings in Nuveen ESG Large-Cap Value ETF (BATS:NULV)
LexAurum Advisors LLC raised its position in shares of Nuveen ESG Large-Cap Value ETF (BATS:NULV – Free Report) by 83.1%...
Financial Contrast: Automotive Properties Real Estate Investment Trust (OTCMKTS:APPTF) versus Gladstone Land (NASDAQ:LAND)
Gladstone Land (NASDAQ:LAND – Get Free Report) and Automotive Properties Real Estate Investment Trust (OTCMKTS:APPTF – Get Free Report) are...